Literature DB >> 34380027

GDF15 mediates the metabolic effects of PPARβ/δ by activating AMPK.

David Aguilar-Recarte1, Emma Barroso1, Anna Gumà2, Javier Pizarro-Delgado1, Lucía Peña1, Maria Ruart1, Xavier Palomer1, Walter Wahli3, Manuel Vázquez-Carrera4.   

Abstract

Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) activates AMP-activated protein kinase (AMPK) and plays a crucial role in glucose and lipid metabolism. Here, we examine whether PPARβ/δ activation effects depend on growth differentiation factor 15 (GDF15), a stress response cytokine that regulates energy metabolism. Pharmacological PPARβ/δ activation increases GDF15 levels and ameliorates glucose intolerance, fatty acid oxidation, endoplasmic reticulum stress, and inflammation, and activates AMPK in HFD-fed mice, whereas these effects are abrogated by the injection of a GDF15 neutralizing antibody and in Gdf15-/- mice. The AMPK-p53 pathway is involved in the PPARβ/δ-mediated increase in GDF15, which in turn activates again AMPK. Consistently, Gdf15-/- mice show reduced AMPK activation in skeletal muscle, whereas GDF15 administration results in AMPK activation in this organ. Collectively, these data reveal a mechanism by which PPARβ/δ activation increases GDF15 levels via AMPK and p53, which in turn mediates the metabolic effects of PPARβ/δ by sustaining AMPK activation.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AMPK; GDF15; PPARβ/δ; glucose tolerance; p53

Mesh:

Substances:

Year:  2021        PMID: 34380027     DOI: 10.1016/j.celrep.2021.109501

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  6 in total

Review 1.  GDF15: a potential therapeutic target for type 1 diabetes.

Authors:  Soumyadeep Sarkar; John T Melchior; Hayden R Henry; Farooq Syed; Raghavendra G Mirmira; Ernesto S Nakayasu; Thomas O Metz
Journal:  Expert Opin Ther Targets       Date:  2022-02-09       Impact factor: 6.902

Review 2.  Growth Differentiation Factor-15 in Immunity and Aging.

Authors:  Brandt D Pence
Journal:  Front Aging       Date:  2022-02-09

3.  Camptothecin effectively treats obesity in mice through GDF15 induction.

Authors:  Jun Feng Lu; Meng Qing Zhu; Bao Cai Xie; Xiao Chen Shi; Huan Liu; Rui Xin Zhang; Bo Xia; Jiang Wei Wu
Journal:  PLoS Biol       Date:  2022-02-24       Impact factor: 8.029

Review 4.  Coping With Stress: The Mitokine GDF-15 as a Biomarker of COVID-19 Severity.

Authors:  Darakhshan Sohail Ahmed; Stéphane Isnard; Carolina Berini; John Lin; Jean-Pierre Routy; Léna Royston
Journal:  Front Immunol       Date:  2022-02-16       Impact factor: 7.561

5.  Overexpression of NAG-1/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated dsDNA release and AIM2 inflammasome activation.

Authors:  Ying Wang; Chaojie Chen; Jiajun Chen; Tingting Sang; He Peng; Xiaojian Lin; Qian Zhao; Shengjia Chen; Thomas Eling; Xingya Wang
Journal:  Redox Biol       Date:  2022-04-27       Impact factor: 10.787

6.  GDF15 Contributes to Radioresistance by Mediating the EMT and Stemness of Breast Cancer Cells.

Authors:  Xinrui Zhao; Xinglong Liu; Songling Hu; Yan Pan; Jianghong Zhang; Guomei Tai; Chunlin Shao
Journal:  Int J Mol Sci       Date:  2022-09-18       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.